-
Overview of treatment for relapsed neuroblastoma Dr Lucas Moreno Spain
-
Towards tailored screening Should breast cancer screening programs routinely measure mammographic density Jennifer Stone
-
The lived experience of breast cancerÂrelated lymphoedema Jane Turner
-
Making medicine safe - lessons from Boeing, Hopkins & Tom Hanks Anthony Joshua
-
Overview of treatment for low and intermediate risk Neuroblastoma patients Dr Gudrun Schleiermacher Institut Curie, France
-
Angelo Dei Tos Genetics of Sarcomas
-
Improving outcomes in High Risk Neuroblastoma Professor Julie Park Seattle Children's Hospital
-
Melanoma MDT panel discussion Chair Alexander Menzies
-
Clare Scott Molecular classification of ovarian cancer
-
Psychological Issues in Male Breast Cancer Jemma Gilchrist
-
Sleepless after breast cancer Panel Discussion
-
Moffitt clinical pathways translating evidence into standardized practice Dana Rollison
-
Stephen Fox Tumour classification morphology and molecular, two sides of the same coin
-
My Story Ian Cant
-
Overview of neuroblastoma epidemiology and genetic predisposition Dr Sharon Diskin Children's Hospital of Philadelphia, USA
-
Self management of cancer pain Case Studies
-
Angelo Dei Tos The challenge of rare cancers
-
Patient Safety Deviation or deviant (human error, system or cultural failures)
-
Late effects in neuroblastoma survivors An Update Dr Lisa Diller Professor of Pediatrics, Harvard Medical School
-
Radiation therapy in older patients with early breast cancer Claire Phillips
-
Heather Cunliffe Small cell cancer of the ovary
-
Physiotherapy strategies for cancer pain Sharni Patchell
-
Patient selection and biomarkers for immunotherapy in lung cancer Matthew D. Hellmann
-
Pain in cancer survivors Prof Paul Glare
